12 Health Care Stocks Moving In Monday's After-Market Session

Adaptimmune Therapeutics (NASDAQ:ADAP) stock rose 12.7% to $1.6 during Monday's after-market session. The market value of their outstanding shares is at $258.9 million.
Epizyme (NASDAQ:EPZM) shares rose 11.57% to $0.56. The market value of their outstanding shares is at $92.3 million. As per the news, the Q1 earnings report came out 4 days ago.
INVO Bioscience (NASDAQ:INVO) stock rose 10.25% to $1.72. The market value of their outstanding shares is at $20.7 million. The company's, Q1 earnings came out today.
NantHealth (NASDAQ:NH) shares increased by 10.11% to $0.65. The company's market cap stands at $75.0 million.
Adial Pharmaceuticals (NASDAQ:ADIL) stock increased by 9.85% to $1.56. The company's market cap stands at $37.0 million. The company's, Q1 earnings came out today.
Revelation Biosciences (NASDAQ:REVB) shares moved upwards by 8.66% to $0.74. The company's market cap stands at $11.1 million. As per the press release, Q1 earnings came out today.

NeuroOne Medical Tech (NASDAQ:NMTC) shares decreased by 14.1% to $0.5 during Monday's after-market session. The company's market cap stands at $8.0 million. As per the news, the Q2 earnings report came out 2 days ago.
Femasys (NASDAQ:FEMY) stock declined by 9.64% to $1.5. The company's market cap stands at $17.7 million. The company's, Q1 earnings came out 3 days ago.
Adamis Pharmaceuticals (NASDAQ:ADMP) stock declined by 9.6% to $0.42. The market value of their outstanding shares is at $62.8 million. As per the news, the Q1 earnings report came out today.
Acer Therapeutics (NASDAQ:ACER) stock decreased by 9.23% to $1.87. The company's market cap stands at $28.6 million. The company's, Q1 earnings came out today.
Aspira Womens Health (NASDAQ:AWH) shares declined by 8.11% to $0.53. Trading volume for this security closed at 80.3K, accounting for 16.8% of its average full-day volume over the last 100 days. The company's market cap stands at $59.8 million. As per the news, the Q1 earnings report came out 3 days ago.
SCYNEXIS (NASDAQ:SCYX) stock fell 7.66% to $1.93. The market value of their outstanding shares is at $56.3 million. The company's, Q1 earnings came out 2 days ago. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.